To celebrate our 2022 Year in Review series, we decided to publish a new visualisation of our Psychedelic Drug Development Tracker data: a bullseye chart. Part of our Year in Review series Access a PDF version of the chart for a higher-resoluton copy and contact us at [email protected] with any questions. Browse our interactive Psychedelic Drug Development Tracker for more detail…

Source

Previous articleIsraeli- Based Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
Next articleBright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements